Literature DB >> 10325316

Epidemiology of visceral mycoses: analysis of data in annual of the pathological autopsy cases in Japan.

T Yamazaki1, H Kume, S Murase, E Yamashita, M Arisawa.   

Abstract

The data on visceral mycoses that had been reported in the Annual of the Pathological Autopsy Cases in Japan from 1969 to 1994 by the Japanese Society of Pathology were analyzed epidemiologically. The frequency of visceral mycoses among the annual total number of pathological autopsy cases increased noticeably from 1.60% in 1969 to a peak of 4.66% in 1990. Among them, the incidences of candidiasis and aspergillosis increased the most. After 1990, however, the frequency of visceral mycoses decreased gradually. Until 1989, the predominant causative agent was Candida, followed in order by Aspergillus and Cryptococcus. Although the rate of candidiasis decreased by degrees from 1990, the rate of aspergillosis increased up to and then surpassed that of candidiasis in 1991. Leukemia was the major disease underlying the visceral mycoses, followed by solid cancers and other blood and hematopoietic system diseases. Severe mycotic infection has increased over the reported 25-year period, from 6.6% of the total visceral mycosis cases in 1969 to 71% in 1994. The reasons for this decrease of candidiasis combined with an increase of aspergillosis or of severe mycotic infection might be that (i) nonsevere (not disseminated) infections were excluded from the case totals, since they have become controllable by antifungal drugs such as fluconazole, but (ii) the available antifungal drugs were not efficacious against severe infections such as pulmonary aspergillosis, and (iii) the number of patients living longer in an immunocompromised state had increased because of developments in chemotherapy and progress in medical care.

Entities:  

Mesh:

Year:  1999        PMID: 10325316      PMCID: PMC84937     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

Review 1.  Invasive aspergillosis.

Authors:  D W Denning
Journal:  Clin Infect Dis       Date:  1998-04       Impact factor: 9.079

2.  A statistical survey of deep fungus infection in Japan.

Authors:  M Miyake; M Okudaira
Journal:  Acta Pathol Jpn       Date:  1967-08

3.  Recent statistical survey of visceral aspergillosis in Japan, and experimental studies on the pathogenicity of Aspergillus fumigatus in rabbits.

Authors:  M Okudaira; H Kume; H Kurata; F Sakabe
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1986-07

4.  Present state of fungal infections in autopsy cases in Japan.

Authors:  M Hotchi; M Okada; T Nasu
Journal:  Am J Clin Pathol       Date:  1980-10       Impact factor: 2.493

5.  Detection of circulating candida enolase by immunoassay in patients with cancer and invasive candidiasis.

Authors:  T J Walsh; J W Hathorn; J D Sobel; W G Merz; V Sanchez; S M Maret; H R Buckley; M A Pfaller; R Schaufele; C Sliva
Journal:  N Engl J Med       Date:  1991-04-11       Impact factor: 91.245

6.  [Clinical evaluation of fluconazole in patients with mycotic infection].

Authors:  T Matsushima; H Ikeda; S Tomizawa; J Nakamura; M Adachi; M Kawanishi; J Tanabe; Y Tano
Journal:  Jpn J Antibiot       Date:  1989-01

Review 7.  Secondary mycosis in surgery: treatment with fluconazole.

Authors:  P Kujath; K Lerch
Journal:  Infection       Date:  1989 Mar-Apr       Impact factor: 3.553

8.  A clinical study of fluconazole for the treatment of deep mycoses.

Authors:  H Ikemoto
Journal:  Diagn Microbiol Infect Dis       Date:  1989 Jul-Aug       Impact factor: 2.803

9.  Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System.

Authors:  S N Banerjee; T G Emori; D H Culver; R P Gaynes; W R Jarvis; T Horan; J R Edwards; J Tolson; T Henderson; W J Martone
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

10.  Fungal infections in cancer patients: an international autopsy survey.

Authors:  G Bodey; B Bueltmann; W Duguid; D Gibbs; H Hanak; M Hotchi; G Mall; P Martino; F Meunier; S Milliken
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-02       Impact factor: 3.267

View more
  14 in total

1.  Impact of zygomycosis on microbiology workload: a survey study in Spain.

Authors:  Marta Torres-Narbona; Jesús Guinea; José Martínez-Alarcón; Patricia Muñoz; Ignacio Gadea; Emilio Bouza
Journal:  J Clin Microbiol       Date:  2007-03-28       Impact factor: 5.948

2.  Diagnosis of invasive aspergillosis and mucormycosis in immunocompromised patients by seminested PCR assay of tissue samples.

Authors:  V Rickerts; G Just-Nübling; F Konrad; J Kern; E Lambrecht; A Böhme; V Jacobi; R Bialek
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-01       Impact factor: 3.267

3.  The Postmortem Features of Mucormycosis.

Authors:  Tracy S Halvorson; Alexandra L Isaacson; Bradley A Ford; Dennis J Firchau
Journal:  Acad Forensic Pathol       Date:  2020-11-25

Review 4.  Novel perspectives on mucormycosis: pathophysiology, presentation, and management.

Authors:  Brad Spellberg; John Edwards; Ashraf Ibrahim
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

Review 5.  Economic evaluations of treatments for systemic fungal infections: a systematic review of the literature.

Authors:  Simon Dixon; Emma McKeen; Margaret Tabberer; Suzy Paisley
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 6.  Pulmonary cryptococcosis in late pregnancy and review of published literature.

Authors:  Shigeki Nakamura; Koichi Izumikawa; Masafumi Seki; Hiroshi Kakeya; Yoshihiro Yamamoto; Katsunori Yanagihara; Yoshitsugu Miyazaki; Shigeru Kohno
Journal:  Mycopathologia       Date:  2008-10-18       Impact factor: 2.574

Review 7.  CNS aspergillosis: recognition, diagnosis and management.

Authors:  Markus Ruhnke; Grzegorz Kofla; Kirsten Otto; Stefan Schwartz
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

8.  Antifungal susceptibilities of opportunistic filamentous fungal pathogens from the Asia and Western Pacific Region: data from the SENTRY Antifungal Surveillance Program (2011-2019).

Authors:  Michael A Pfaller; Cecilia G Carvalhaes; Paul Rhomberg; Shawn A Messer; Mariana Castanheira
Journal:  J Antibiot (Tokyo)       Date:  2021-06-30       Impact factor: 2.649

Review 9.  Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients.

Authors:  Georg Maschmeyer; Antje Haas; Oliver A Cornely
Journal:  Drugs       Date:  2007       Impact factor: 11.431

10.  Rare complication of bronchoesophageal fistula due to pulmonary mucormycosis after induction chemotherapy for acute myeloid leukemia: a case report.

Authors:  Jun-Hyung Lee; Jin-Soo Hyun; Da-Yeong Kang; Hee-Jeong Lee; Sang-Gon Park
Journal:  J Med Case Rep       Date:  2016-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.